Dermsquared

Dermsquared The leading platform built by dermatologists for dermatologists to elevate patient care

04/30/2026

How much visibility do you have into compounded therapies your patients receive?​

In Derms and Conditions, James Q. Del Rosso, DO and Stefan Weiss, MD, discuss the variability, limited testing, and regulatory differences that can impact compounded medications, particularly in 503A pharmacies.​

The episode highlights where uncertainty can affect efficacy, safety, and clinical decision-making and how to approach these therapies more deliberately in practice.​

Tune in to the episode to hear what factors clinicians should consider when working with compounded therapies.​

πŸ”— Listen now: https://bit.ly/3OV1XjQ
​
​

04/29/2026

Your patient has psoriasis AND joint pain. Now what?

If you've ever hesitated on that handoff, this session is for you.

Co-chair David Seiter, NP-C, takes the PANP360 Scottsdale stage with two of the most under-addressed conversations in derm right now:

Connecting the derm ↔ rheumatology dots in psoriatic arthritis
Rethinking prurigo nodularis in light of a completely new treatment landscape

🌟 David doesn't just teach it, he practices it regularly. Between patients and KOL engagements, he helped create this community alongside Cynthia Trickett, PA-C, so NPs and PAs have a room built for how actual practice.

3 days. 12 π˜ˆπ˜”π˜ˆ π˜—π˜™π˜ˆ 𝘊𝘒𝘡𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦π˜₯π˜ͺπ˜΅π˜΄β„’

SAVE 50% 🫰🏽on your registration fee when you enter David Seiter's code: Scottsdale

May 29–31 β€’ Westin Kierland Resort and Spa, Scottsdale, AZ

Can't come to Scottsdale?
Join us in Boston! August 14-16 β€’ Boston Marriott Copley Place

Seats are filling. Save yours today. Register here: https://bit.ly/3R7ONAw

04/28/2026

A note from our PANP360 co-chair, Harrison Nguyen MD, MBA, MPH.

PANP360 was built around a simple idea: dermatology PAs and NPs deserve a room that reflects how they actually practice. High volume. Real-world constraints. Risk-aware decision-making. Cases that ask more of us than the textbook can answer.

In 2026, we're opening that room twice:
β–ͺ️ PANP360 Scottsdale β€” May 29–31, 2026 | Westin Kierland Resort & Spa
β–ͺ️ PANP360 Boston β€” August 14–16, 2026 | Boston Marriott Copley Place

Earn up to 12 π˜ˆπ˜”π˜ˆ π˜—π˜™π˜ˆ 𝘊𝘒𝘡𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦π˜₯π˜ͺπ˜΅π˜΄β„’

The curriculum is case-based and hands-on. We focus on managing adverse events, off-label nuance, insurance realities, and the disease states you treat most across medical, surgical, and aesthetic dermatology.

Sessions are intentionally structured for substantive dialogue, and the faculty practice the way you do.

For clinicians committed to clinical depth, peer collaboration, and real-world application β€” we'd be honored to have you with us.

Register for Scottsdale or Boston here β†’ https://bit.ly/4eaTPG8

04/24/2026

Microneedling is widely used, but technique and expectations aren’t always aligned.

Dr. Cherie Frey, FAAD, joins Gary Goldenberg MD, to discuss how microneedling is used in practice:
-controlled injury to the dermis to stimulate collagen production, with up to a 400% increase in some studies across a series of treatments.

Depth isn’t uniform. Thicker areas like the cheeks can tolerate 1.0-1.5 mm to reach the dermis, while thinner areas require a lighter approach.

Dr. Frey makes the case for building around the procedure. If the goal is collagen, pretreatment with retinoids, vitamin C, and peptides isn’t optional; it’s part of the strategy. And usually she pairs microneedling with PRP (and often exosomes) for improved healing and response.

The full conversation moves beyond technique and into melasma as a multi-layer disease, how risk assessment really works with energy-based devices, and why the field is shifting toward prevention over correction.

Listen to the full episode here: https://bit.ly/4eyoYmW

04/23/2026

Faster approvals come from knowing how to work prior auths, appeals, and documentation.

PAMS is the only one-day, in-person training built for biologics coordinators and access teams.

Led by experts in the field, you’ll learn how to move medications through faster and earn your C-PAM certification.

Chicago | April 25
Up to $1,000 in support.

Register here: https://bit.ly/4u1iAJy

04/23/2026

There is more than one way to target the PD-1/PD-L1 immune checkpoint pathway in advanced cutaneous squamous cell carcinoma (cSCC), and the differences matter clinically.

In just 10 minutes, Vishal Patel, MD, and David M. Miller, MD, PhD, walk through how to distinguish these agents by mechanism, weigh their efficacy and safety profiles, and factor in patient-specific considerations when selecting a checkpoint inhibitor for cSCC.

Earn up to 0.25 π˜ˆπ˜”π˜ˆ π˜—π˜™π˜ˆ 𝘊𝘒𝘡𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦π˜₯π˜ͺπ˜΅π˜΄β„’

This activity is supported by an educational grant from Sun Pharmaceutical Industries Ltd.

Start the activity: https://bit.ly/4cEhHPU

04/22/2026

Many acne patients aren’t starting with intact skin. They have barrier disruption, microbiome shifts, and irritation in play.

In this episode, Heather Woolery-Lloyd, MD, and James Del Rosso, DO, get into what that means in practice.

pH, tolerability, and why outcomes depend on everything around the prescription. It’s not a shift in what we use, but how we use it.

Listen here: https://bit.ly/4vEm4n3

04/22/2026

Most delays in dermatologic care happen on the operational side.

PAMS is the only one-day, in-person training focused on all things access:

βœ… reducing delays
βœ… strengthening appeals
βœ… building workflows that hold up in clinic

And just as important, being in the room with people who do this every day.

Chicago | April 25
Up to $1,000 in support.

Register here: https://bit.ly/4u1iAJy

04/21/2026

April 25th in Chicago.

If you work in access, you already know where things break down.

PAMS is a one-day training focused on moving biologics through, with practical tips and tricks you can take back to the clinic right away.

As Foday Koroma, FNP-BC, puts it: refine your approach and pick up the small things that help patients start treatment sooner.

Earn up to $1,000 in support.
Use code FODAY to waive registration.
Register here: https://bit.ly/42l5wTn

Mark your calendars for πŸ“Boston. πŸ“… August 14–16, 2026.Earn up to 13 π˜ˆπ˜”π˜ˆ π˜—π˜™π˜ˆ 𝘊𝘒𝘡𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦π˜₯π˜ͺπ˜΅π˜΄β„’. Built for real practice...
04/19/2026

Mark your calendars for πŸ“Boston. πŸ“… August 14–16, 2026.

Earn up to 13 π˜ˆπ˜”π˜ˆ π˜—π˜™π˜ˆ 𝘊𝘒𝘡𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦π˜₯π˜ͺπ˜΅π˜΄β„’. Built for real practice.

PANP360 East registration is now live! Join us for three days of medical, aesthetic, and procedural dermatology designed for derm PAs and NPs who want education that translates to Monday morning clinic.

Build meaningful relationships with colleagues from across the country. Share your approach. Compare notes. Help shape the future of dermatology care through optional research and focus groups.

Mark your calendar. Bring your hardest cases. The room rises together!

Register today and join us: https://bit.ly/4csyYLT

Join us at PANP360 Immersive in Philadelphia tomorrow for an interactive workshop on integrating GLP-1s into psoriasis m...
04/17/2026

Join us at PANP360 Immersive in Philadelphia tomorrow for an interactive workshop on integrating GLP-1s into psoriasis management.

Led by a multi-specialty faculty panel including Payette, MD, MBA, Amaro, MD, Yu, PA-C, and patient advocate Otilia Espinoza, this session covers the obesity-psoriasis connection, latest clinical evidence on GLP-1 use, and real-world strategies for addressing provider and patient challenges.

Earn up to 1.0 π˜ˆπ˜”π˜ˆ π˜—π˜™π˜ˆ 𝘊𝘒𝘡𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦π˜₯π˜ͺπ˜΅π˜΄β„’.

This activity is supported by an educational grant from Lilly.

Going? Add this session to your calendar! Or register for PANP360 Immersive 2026 at: https://bit.ly/4vBskMd

Can a prompt response to atopic dermatitis (AD) in children help with stature? In this on-demand session, (Lisa) A. Swa...
04/17/2026

Can a prompt response to atopic dermatitis (AD) in children help with stature?

In this on-demand session, (Lisa) A. Swanson, MD, G. Bunick, MD, PhD, and K. Golant, MD, explore the risk of short stature in pediatric patients with AD and how biologics may play a role in prevention.

You will learn to:
-Recognize the risk of short stature in pediatric patients with AD
-Describe the safety and efficacy profiles of biologics for pediatric AD based on current clinical evidence
-Apply current clinical data to guide the use of biologics in pediatric AD to prevent short stature

Earn up to 0.5 π˜ˆπ˜”π˜ˆ π˜—π˜™π˜ˆ 𝘊𝘒𝘡𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦π˜₯π˜ͺπ˜΅π˜΄β„’

This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals, Inc.

Start the activity here: https://bit.ly/4cx4qsv

Address

Miami, FL

Website

Alerts

Be the first to know and let us send you an email when Dermsquared posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category